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Narrowing the Candidate Region for Congenital
Diaphragmatic Hernia in Chromosome 15q26:
Contradictory Results
To the Editor:
Subtelomeric screening and FISH analysis of a 13-year-
old girl with severe mental retardation, intrauterine
growth retardation, microcephaly, facial dysmorphisms,
hypoplastic kidney, and short hands and feet but without
congenital diaphragmatic hernia (CDH [MIM 142340])
allowed us to ﬁnd a de novo deletion in 15q26.1–26.2.
That region, as shown by Klaassens et al. (2005) in
a study published in the May issue of the Journal, con-
tains a candidate region for CDH, a condition that oc-
currs in ∼1 of 3,000 newborns and is associated with a
30%–60% mortality rate, with signiﬁcant morbidity
among survivors (Harrison et al. 1994; Nobuhara et al.
1996). The etiology of this condition is barely known
and, in most cases, is considered idiopathic, whereas
∼15% of patients with CDH show chromosomal ab-
normalities. Recently, Biggio et al. (2004) reported on a
child with a 15q26.1 deletion showing CDH, coarcta-
tion of the aorta, and dysmorphic features, suggesting
this region as the possible candidate locus for CDH.
Furthermore, the authors proposed myocyte-speciﬁc en-
hancer factor–2A (MEF2A [MIM 600660]) as a can-
didate gene for CDH, coding for a protein playing a
critical role in the control of muscle differentiation and
development. Klaassens et al. (2005) found 7% numer-
ical and 5% structural chromosome abnormalities in
200 CDH patients. The most frequent chromosome ab-
normality was 15q deletion. Eventually, they determined
the size of the deletions in seven patients with CDH.
They incorporated data from two patients with terminal
15q deletions without CDH, and data from one patient
with a small 15q interstitial deletion and CDH. A min-
imal deletion region, spanning ∼5 Mb at chromosome
bands 15q26.1–15q26.2, has been suggested by these
authors. Two of the known genes of this region, namely,
NR2F2 (MIM 107773) and CDH2 (MIM 602119),
were considered to be the best candidates for CDH.
To better deﬁne the deletion in our patient, FISH ex-
periments were carried out with a set of linearly ordered
BACs selected by human NCBI Map Viewer (build 35.1)
and provided by the Sanger Institute. This analysis
showed that the BAC RP11-386M24, localized to chro-
mosome band 15q26.1 (∼9.0 Mb from the end of the
chromosome), was the closest to the telomere that hy-
bridized on both chromosomes in all examined met-
aphases. The immediately more centromeric CTD—
2313J17 BAC showed signals of different intensities on
the 15q telomeres, suggesting that the breakpoint lay
within this BAC, whereas the overlapping RP11-437B10
BAC and all the distally placed BACs showed no hy-
bridization signal (data not shown).
We thus compared our results with the most signiﬁ-
cant previously characterized 15q deletions, including
ring chromosome 15, unbalanced translocations, and
pure 15qter monosomies, either associated with the
CDH phenotype or not. As shown in ﬁgure 1, no clear
critical region can be drawn from these data, essentially
because case 12 with CDH carried a ring (15) resulting
in a smaller deletion than cases 1, 2, and 3, without
CDH. At least two hypotheses can be made to explain
these contradictory data. First, it is possible that hap-
loinsufﬁciency of the CDH locus has a reduced pene-
trance and that data from patients without CDH could
be useless in establishing the critical region. If this is
true, the candidate region is restricted to ∼3.5 Mb (ﬁg.
1) and includes the NR2F2 gene, but its telomeric limit
is more distal than that deﬁned by Klaassens et al.
(2005), which was derived from a deletion of a patient
without CDH (ﬁg. 1, case 13). On the other hand, draw-
ing genotype-phenotype relationships may be difﬁcult in
ring carriers because of the potential instability of ring
chromosomes that can be associated with gain or loss
of genetic material in other tissues (Tu¨mer et al. 2004).
If we omit ring cases from the analysis, then the critical
region would be narrowed to a 0.7-Mb genomic portion
(ﬁg. 1). The NR2F2 gene, in this case, would be located
outside this putative critical region.
The ST8 alpha-N-acetyl-neuraminide alpha-2, 8-sia-
lyltransferase 2 gene (ST8SIA2 [MIM 602546]) is the
unique known gene in this region and encodes for a type
II membrane protein that catalyzes the transfer of sialic
acid from CMP-sialic acid to the neural cell adhesion
molecules (NCAMs) (Ong et al. 1998). The ST8SIA2
gene is expressed in many tissues during development
(Angata et al. 1997). Evidence suggests that polysialy-
Figure 1 Graphical representation of 15q deletions in patients with and without CDH. The most signiﬁcant BAC clones analyzed are
shown on the left. Solid boxes represent deleted regions, hatched boxes indicate the uncertainty of the breakpoints, and open boxes reveal the
normal chromosomal regions. The green rectangle includes the narrowed candidate CDH region, taking into account only cases with CDH,
whereas the red rectangle indicates the critical region resulting when the ring cases are omitted from the analysis. Patient 1, our case; patient
2, To¨nnies et al. 2001; patient 3, Rogan et al. 1996 (patient K); patients 4–11 and 13, Klaassens et al. 2005 (cases 9, 7, 6, 4, 1, 2, 3, 5, and
8, respectively); patient 12, Tu¨mer et al. 2004 (case 1).
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lated NCAMs promote cell migration and, thus, they
are thought to play a critical role in development. More
speciﬁcally, it has been shown that, during diaphrag-
matic morphogenesis, the expression of polysialylated
NCAMs is tightly modulated along each stage of my-
ogenesis (Allan and Greer 1998).
Finally, although it is less likely, we cannot exclude
the possibility that both the mentioned hypotheses are
true. In this case, the critical region would be represented
by the extent of the deletion in patient 8 (ﬁg. 1).
Additional ﬁndings are needed to reﬁne the search for
a CDH gene in 15q chromosome. However, it seems
likely that NR2F2 and ST8SIA2 are the best candidates.
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Reply to Castiglia et al.
To the Editor:
In response to our article in the May issue of the Journal
(Klaassens et al. 2005), Castiglia et al. (2005 [in this
issue]) address the strategy of including patients with a
15q deletion but without congenital diaphragmatic her-
nia (CDH). They deﬁned a deletion on 15q26.1–26.2 in
a girl with multiple congenital anomalies but without
CDH. Combining data from this patient with previously
published data from two patients with a 15q deletion
but without CDH (Rogan et al. 1996; Tonnies et al.
2001), Castiliglia et al. (2005) found a discrepancy be-
tween our data and the CDH locus that they determined.
Of the two hypotheses postulated to explain these con-
tradictory results, we support the ﬁrst one, which sug-
gests that including patients without CDH in the analysis
might be inappropriate because of the possibility that
heterozygous deletion of a part of 15q (which results in
haploinsufﬁciency for this locus) might not be com-
pletely penetrant. Incomplete penetrance could also ex-
plain, in part, the variability in phenotype of patients
with CDH and a 15q deletion.
Since the publication of our article, we have been able
to more precisely deﬁne the deletions in our patientswith
CDH. With CDH patients only, a 4-Mb common CDH
region would be located between BAC clones RP11–
